Utility of RET mutation analysis in multiple endocrine neoplasia type 2.

doi:10.5858/1999-123-1047-UORMAI

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Utility of RET mutation analysis in multiple endocrine neoplasia type 2.

Archives of pathology & laboratory medicine - 1 Nov 1999

Noll W W

Abstract excerpt

OBJECTIVE: To review the role of RET mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) and in presymptomatic screening for this disorder. DATA SOURCES: Review of the medical literature and current clinical practice. CONCLUSIONS: RET mutation analysis is a sensitive and specific test for MEN 2. It plays a pivotal role in the diagnosis and management of patients and families with MEN...

Topics

Adrenal Gland Neoplasms
DNA Mutational Analysis
Drosophila Proteins
Genetic Counseling
Genotype
Humans
Multiple Endocrine Neoplasia Type 2a
Phenotype
Pheochromocytoma
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-ret
Proto-Oncogenes
Receptor Protein-Tyrosine Kinases
Sensitivity and Specificity
Thyroid Neoplasms

Source

Open in PubMed

Identifiers

PMID: 10539905
DOI: 10.5858/1999-123-1047-UORMAI

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics